| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,087 |
33,036 |
$3.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,642 |
25,315 |
$2.38M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,641 |
15,510 |
$1.54M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,913 |
2,143 |
$526K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,691 |
1,252 |
$479K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,868 |
2,386 |
$440K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,097 |
1,102 |
$368K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,316 |
4,522 |
$348K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,776 |
3,417 |
$319K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,460 |
2,772 |
$304K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,674 |
1,384 |
$213K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,783 |
3,040 |
$213K |
| 36415 |
Collection of venous blood by venipuncture |
27,352 |
22,734 |
$179K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,521 |
4,078 |
$170K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,590 |
6,309 |
$161K |
| 80053 |
Comprehensive metabolic panel |
12,278 |
9,758 |
$142K |
| G0378 |
Hospital observation service, per hour |
9,400 |
3,841 |
$137K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,991 |
2,117 |
$136K |
| 76641 |
|
1,886 |
1,648 |
$134K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,127 |
1,868 |
$107K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
17,888 |
13,505 |
$99K |
| 87088 |
|
6,825 |
5,911 |
$97K |
| 71046 |
Radiologic examination, chest; 2 views |
5,523 |
4,975 |
$89K |
| 84702 |
|
12,726 |
10,546 |
$85K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,666 |
1,993 |
$83K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,459 |
1,118 |
$77K |
| 85027 |
|
3,402 |
2,742 |
$76K |
| 87631 |
|
1,037 |
997 |
$70K |
| 86850 |
|
3,523 |
2,936 |
$67K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
388 |
310 |
$62K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,620 |
1,481 |
$62K |
| 87486 |
|
2,606 |
2,381 |
$60K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
541 |
443 |
$60K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,127 |
1,529 |
$59K |
| 86900 |
|
4,479 |
3,701 |
$59K |
| 97162 |
|
538 |
440 |
$58K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,885 |
2,645 |
$56K |
| 76770 |
|
853 |
760 |
$54K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,820 |
2,495 |
$51K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
493 |
321 |
$45K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,112 |
1,852 |
$40K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
574 |
424 |
$37K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,569 |
2,171 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32,945 |
24,925 |
$36K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
25 |
24 |
$36K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,580 |
366 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
7,479 |
6,034 |
$31K |
| 96112 |
|
111 |
98 |
$31K |
| 93976 |
|
930 |
839 |
$29K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
41 |
41 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
627 |
595 |
$27K |
| 81001 |
|
14,159 |
11,988 |
$26K |
| 84484 |
|
7,563 |
4,608 |
$26K |
| 88307 |
|
438 |
313 |
$25K |
| 73610 |
|
517 |
473 |
$24K |
| 58662 |
|
87 |
74 |
$24K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
169 |
148 |
$23K |
| 82962 |
|
4,908 |
2,577 |
$21K |
| 81003 |
|
5,803 |
5,001 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,094 |
6,360 |
$20K |
| 73562 |
|
788 |
669 |
$18K |
| 82731 |
|
199 |
180 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,166 |
1,022 |
$18K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,708 |
1,235 |
$16K |
| 76801 |
|
1,895 |
1,498 |
$16K |
| 77066 |
Tomosynthesis, mammo |
603 |
531 |
$16K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
956 |
854 |
$15K |
| 81025 |
|
1,923 |
1,758 |
$15K |
| 76882 |
|
267 |
249 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,172 |
1,870 |
$14K |
| 77072 |
|
398 |
385 |
$13K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
167 |
139 |
$12K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
130 |
125 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
732 |
641 |
$12K |
| 76830 |
Ultrasound, transvaginal |
977 |
876 |
$11K |
| 73630 |
|
408 |
364 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,646 |
7,661 |
$10K |
| 87186 |
|
1,178 |
943 |
$10K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
72 |
64 |
$10K |
| 87040 |
|
3,565 |
1,795 |
$9K |
| 74019 |
|
844 |
799 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,955 |
7,251 |
$8K |
| 87581 |
|
2,609 |
2,382 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,004 |
854 |
$8K |
| 86140 |
|
2,306 |
2,066 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,944 |
1,736 |
$7K |
| 84112 |
|
274 |
237 |
$7K |
| 85610 |
|
6,673 |
5,208 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,303 |
1,886 |
$7K |
| 74021 |
|
296 |
274 |
$7K |
| 80061 |
Lipid panel |
1,826 |
1,485 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,090 |
3,187 |
$6K |
| 73130 |
|
119 |
95 |
$6K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
51 |
50 |
$6K |
| 83690 |
|
5,256 |
4,345 |
$5K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
802 |
706 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
3,725 |
2,947 |
$5K |
| 80076 |
|
2,425 |
2,022 |
$5K |
| 85730 |
|
4,568 |
3,613 |
$5K |
| 93971 |
|
469 |
376 |
$5K |
| 59025 |
Fetal non-stress test |
351 |
296 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,935 |
3,914 |
$5K |
| 83615 |
|
1,022 |
747 |
$5K |
| 77062 |
|
390 |
371 |
$4K |
| 73110 |
|
176 |
152 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,466 |
2,717 |
$4K |
| 97161 |
|
75 |
54 |
$4K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,219 |
563 |
$4K |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
5,100 |
3,516 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
120 |
93 |
$4K |
| 85379 |
|
1,244 |
1,055 |
$4K |
| 73030 |
|
208 |
165 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,651 |
1,728 |
$3K |
| 00840 |
|
720 |
585 |
$3K |
| 87077 |
|
1,275 |
975 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,235 |
2,662 |
$3K |
| 93970 |
|
89 |
77 |
$3K |
| 73140 |
|
82 |
77 |
$3K |
| 87210 |
|
747 |
698 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,405 |
2,127 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,173 |
3,423 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,426 |
2,298 |
$2K |
| 36416 |
|
235 |
170 |
$2K |
| 86901 |
|
4,655 |
3,669 |
$2K |
| 74018 |
|
239 |
211 |
$2K |
| J1756 |
Injection, iron sucrose, 1 mg |
206 |
73 |
$2K |
| 92523 |
|
12 |
12 |
$2K |
| 82248 |
|
1,473 |
948 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,003 |
844 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
949 |
849 |
$2K |
| 87507 |
|
189 |
163 |
$2K |
| 83880 |
|
220 |
167 |
$1K |
| 73590 |
|
13 |
12 |
$1K |
| 72141 |
|
17 |
15 |
$1K |
| 85384 |
|
667 |
495 |
$1K |
| 88304 |
|
74 |
70 |
$1K |
| 71250 |
|
130 |
97 |
$1K |
| 83605 |
|
1,778 |
1,188 |
$1K |
| 83735 |
|
1,005 |
740 |
$1K |
| 82247 |
|
348 |
211 |
$853.23 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
45 |
36 |
$851.42 |
| 77080 |
|
73 |
54 |
$823.44 |
| 76536 |
|
17 |
14 |
$704.55 |
| 82550 |
|
315 |
261 |
$674.79 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
893 |
212 |
$658.90 |
| 73080 |
|
12 |
12 |
$601.70 |
| 84439 |
|
619 |
551 |
$577.55 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
54 |
38 |
$573.15 |
| 82570 |
|
468 |
358 |
$482.17 |
| 88342 |
|
148 |
102 |
$480.93 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
29 |
24 |
$480.93 |
| 70544 |
|
15 |
12 |
$477.44 |
| 85045 |
|
204 |
172 |
$475.37 |
| 84156 |
|
302 |
214 |
$472.35 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
994 |
596 |
$460.66 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
53 |
30 |
$419.74 |
| 76881 |
|
14 |
12 |
$406.66 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
31 |
18 |
$400.34 |
| 82607 |
|
29 |
25 |
$371.53 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
120 |
71 |
$360.00 |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
14 |
13 |
$358.60 |
| 29515 |
|
45 |
38 |
$280.72 |
| 85651 |
|
1,232 |
1,095 |
$277.93 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,882 |
1,370 |
$276.21 |
| 72100 |
|
117 |
106 |
$263.73 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
2,000 |
1,902 |
$188.20 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
587 |
300 |
$171.94 |
| 72040 |
|
18 |
15 |
$170.11 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
96 |
45 |
$166.94 |
| 87081 |
|
228 |
224 |
$142.04 |
| 84550 |
|
875 |
658 |
$125.89 |
| 76870 |
|
42 |
40 |
$119.83 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
215 |
193 |
$118.21 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
175 |
137 |
$114.23 |
| 87070 |
|
79 |
67 |
$72.42 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
68 |
31 |
$68.10 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
12 |
$65.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
12 |
12 |
$65.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
46 |
31 |
$51.58 |
| 51701 |
|
914 |
867 |
$48.61 |
| 82728 |
|
34 |
28 |
$37.42 |
| 87503 |
|
80 |
31 |
$29.22 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
611 |
580 |
$24.59 |
| 29125 |
|
64 |
59 |
$21.63 |
| 84480 |
|
14 |
12 |
$21.13 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
909 |
699 |
$14.08 |
| 82272 |
|
35 |
24 |
$3.09 |
| 87205 |
|
49 |
39 |
$2.61 |
| 84100 |
|
30 |
25 |
$1.56 |
| 12001 |
|
13 |
13 |
$0.00 |
| 96376 |
|
115 |
93 |
$0.00 |
| 94010 |
|
34 |
25 |
$0.00 |
| 86308 |
|
27 |
26 |
$0.00 |
| 83550 |
|
25 |
24 |
$0.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
14 |
14 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
561 |
533 |
$0.00 |
| 12011 |
|
108 |
105 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
212 |
111 |
$0.00 |
| 90715 |
|
15 |
13 |
$0.00 |
| 83540 |
|
43 |
38 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
15 |
12 |
$0.00 |
| 88302 |
|
16 |
12 |
$0.00 |